Der Markt für Embolietherapie wird voraussichtlich von 3.341,49 Millionen US-Dollar im Jahr 2021 auf 5.758,28 Millionen US-Dollar wachsen bis 2028; Es wird geschätzt, dass es von 2022 bis 2028 mit einer CAGR von 8,1 % wachsen wird.
Embolotherapie ist ein Verschluss von Arterien durch Einführen Ballons, Blutgerinnsel, Spiralen oder Gelschaum mit einem Angiographiekatheter. Der Katheter hilft beim Blockieren eines Blutgefäßes, indem ein Ballon oder ein Fremdkörper implantiert wird, um blutende Geschwüre zu behandeln, Fisteln oder arteriovenöse Fehlbildungen zu schließen, Organe zu devaskularisieren, Blutgefäßdefekte zu beseitigen oder inoperable Blutungen zu kontrollieren. Embolotherapie wird auch verwendet, um den Blutfluss zu und um einen Tumor herum während einer Operation zu stoppen.
Der embolotherapy-Markt ist unterteilt in Produkt, Krankheitsindikation, Verfahrensendbenutzer und Geographie. Geografisch ist der Markt grob in Nordamerika, Europa, den asiatisch-pazifischen Raum, den Nahen Osten & Afrika und Süd- & Zentralamerika. Dieser Bericht bietet Einblicke und eingehende Analysen des Marktes mit Schwerpunkt auf Parametern wie Markttrends und Marktdynamik sowie die Wettbewerbsanalyse der weltweit führenden Marktteilnehmer.
Strategische Einblicke
Lukrative Regionen für den Embolotherapie-Markt
Market Insights
Steigende Patientenpräferenz für minimal-invasive Verfahren kurbelt Embolotherapie-Markt an
Die Zahl der minimal-invasiven Operationen steigt, da Patienten solche Operationen aufgrund geringerer postoperativer Schmerzen, postoperativer Komplikationen, kürzere Krankenhausaufenthalte und schnelle Genesungszeiten. Nichtinvasive oder minimalinvasive Behandlungen werden als Alternativen zur Operation für Patientinnen mit Brustkrebs im Frühstadium entwickelt. Beispielsweise ist die transarterielle Chemoembolisation, auch bekannt als TACE, ein minimal-invasives Verfahren, das typischerweise zur Behandlung von hepatozellulärem Karzinom eingesetzt wird. TACE ist für Patienten mit asymptomatischem und inoperablem Leberkrebs bestimmt. TACE kann verwendet werden, um die Größe des Tumors zu verringern und den Patienten für eine Lebertransplantation geeignet zu machen. Es wird als Weiterentwicklung einer früher angewandten Technik namens Trans-catheter Arterial Embolization (TAE) angesehen.
Die Prostataarterienembolisation (PAE) ist ebenfalls eine minimal-invasive Therapie, die als elektive ambulante Technik für Symptome der unteren Harnwege (LUTS) infolge einer benignen Prostatahyperplasie (BPH) durchgeführt wird. Die Zahl der mit PAE behandelten Patienten ist in den letzten Jahren gestiegen. Daher treibt die zunehmende Präferenz für minimal-invasive Verfahren das Wachstum des Marktes für Embolietherapien voran.
Produktinformationen
Basierend auf der Produkt ist der Markt für Embolietherapien in Emboliemittel und Unterstützungsgeräte unterteilt. Das Emboliemittel ist weiter unterteilt in Mikrokügelchen, flüssige Emboliemittel, Emboliespiralen, Emboliestopfensysteme, abnehmbare Ballons und andere. Die Stützvorrichtung ist weiter in Mikrokatheter und Führungsdrähte unterteilt. Das Segment Emboliemittel hält im Jahr 2021 den größten Marktanteil. Darüber hinaus wird erwartet, dass dasselbe Segment im Prognosezeitraum die höchste CAGR verzeichnet. Die wichtigsten Antriebsfaktoren für das Wachstum des Segments Emboliemittel sind die zunehmende Verwendung von Emboliemitteln in verschiedenen interventionelle Radiologie Verfahren und Fortschritte bei Emboliemitteln.
Markt für Embolotherapie, nach Produkt 2022 und 2028
Einblicke in Krankheitsanzeigen
< span>Basierend auf der Krankheitsindikation wird der Markt für Embolietherapie in Krebs, periphere Gefäßerkrankungen , neurologische Erkrankungen, urologische und nephrologische Erkrankungen, gastrointestinale Erkrankungen und andere. Der Krebs wird weiter in Leberkrebs, Nierenkrebs und andere unterteilt. Das Krebssegment wird voraussichtlich 2021 den größten Marktanteil halten. Darüber hinaus wird erwartet, dass dasselbe Segment von 2022 bis 2028 die schnellste CAGR verzeichnen wird. Die wichtigsten treibenden Faktoren für das Wachstum des Krebssegments sind die weltweit steigenden Krebserkrankungen.
Einblicke in Krankheitsanzeigen
Basierend auf der Krankheitsindikation ist der Markt für Embolietherapien unterteilt in Transkatheter-Arterienembolisation (TAE), transkatheterarterielle Radioembolisation (TARE)/selektive interne Strahlentherapie (SIRT) und transarterielle Chemoembolisation (TACE). Das Segment der transkatheterarteriellen Embolisation (TAE) hält den größten Marktanteil im Jahr 2021. Darüber hinaus wird erwartet, dass dasselbe Segment im Zeitraum 2022-2028 die schnellste CAGR verzeichnen wird. Die wichtigsten treibenden Faktoren für das Wachstum des Segments der Transkatheter-arteriellen Embolisation (TAE) sind die zunehmende Präferenz älterer Menschen für minimal-invasive Verfahren, die zunehmende Prävalenz chronischer Krankheiten und das schnelle Wachstum der geriatrischen Bevölkerung.
Erkenntnisse der Endnutzer
< p>Basierend auf dem Endnutzer ist der Markt für Embolietherapie in Krankenhaus- & Klinik, ambulantes chirurgisches Zentrum und andere Endverbraucher. Im Jahr 2021 wird das Krankenhaus & Kliniksegment dürfte den größten Marktanteil halten. Darüber hinaus wird erwartet, dass dasselbe Segment von 2022 bis 2028 die höchste CAGR verzeichnen wird. Die wichtigsten treibenden Faktoren für das Wachstum des Krankenhauses & Kliniksegment sind die zunehmende Einführung minimalinvasiver chirurgischer Verfahren (einschließlich vaskulärer, urologischer und neurologischer Verfahren), eine höhere Patientenfrequenz in Krankenhäusern zur Behandlung verschiedener Krankheiten wie Krebs, eine zunehmende Anzahl von Embolisationsverfahren, die in diesen Einrichtungen durchgeführt werden, eine zunehmende Einführung von Fortschrittliche und hochmoderne Embolotherapiegeräte zur präzisen Durchführung komplexer Eingriffe in großen Krankenhäusern, kleinen Kliniken und Intensivstationen.
Organische Entwicklungen wie Produkteinführungen und -zulassungen sind von Unternehmen auf dem Markt für Embolietherapie stark angenommene Strategien. Nachfolgend sind einige der wichtigsten Marktentwicklungen der letzten Zeit aufgeführt:
- Im April 2022 erhielt die Boston Scientific Corporation die 510(k)-Zulassung der US-amerikanischen Food and Drug Administration (FDA) für die EMBOLD Fibered Detachable Coil, mit der sie behindert werden soll oder den Blutfluss in den peripheren Gefäßen reduzieren. Die EMBOLD Fibered Coil, die neueste Ergänzung des Portfolios der interventionellen Onkologie von Boston Scientific, wurde für den Einsatz bei verschiedenen Embolisationsverfahren entwickelt, einer minimalinvasiven Behandlung, die darauf abzielt, ein oder mehrere Blutgefäße zu blockieren, um den Blutfluss zu behindern oder zu reduzieren.
- Im September 2021 gab Abbott die Übernahme von Walk Vascular bekannt , LLC, ein Unternehmen für Medizinprodukte im kommerziellen Stadium mit einem minimalinvasiven mechanischen Aspirations-Thrombektomiesystem zur Entfernung peripherer Blutgerinnsel. Die peripheren Thrombektomiesysteme von Walk Vascular werden in das bestehende endovaskuläre Produktportfolio von Abbott integriert.
Firmenprofile
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- Johnson & Johnson
- Medtronic
- < span>Acandis GmbH
- SSEM Mthembu Medical (Pty) Ltd
- Balt USA LLC
- Stryker< /li>
- Guerbet LLC
- Terumo Corporation
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Embolotherapy is an occlusion of arteries by introducing balloons, blood clots, coils or gel foam using an angiographic catheter. The catheter aids to block a blood vessel by implanting balloon or any foreign body, in order to treat bleeding ulcer, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defect or for control of inoperable hemorrhage. Embolotherapy is also used to stop blood flow towards and around a tumor during surgery.
The factors driving the growth of the embolotherapy market are rising incidence of cancer cases, rising patient preference for minimally invasive procedures, and increasing incidence of hypertension, obesity, smoking, and alcoholism.
The availability of other alternative therapies, and the high cost of embolotherapy are expected to restrict the embolotherapy market growth during the forecast period.
The embolotherapy market majorly consists of the players, such as as Abbott Laboratories, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson Consumer Inc., Medtronic, Acandis GmbH, Terumo Corporation, Balt USA LLC, Stryker Corporation, and Guerbet LLC, among others.
The global embolotherapy market based on product is bifurcated into embolic agents and support devices. The embolic agents is further sub-segmented into microsphere, liquid embolics agents, embolic coils, embolic plug systems, detachable balloons, and others. The support devices is further sub-segmented into microcatheters, and guidewires. The embolic agents segment is likely to hold the largest market share in 2021. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period
The global embolotherapy market based on regions is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In 2021, the North American area held the largest market share. However, the Asia Pacific region is estimated to grow at the fastest CAGR of 8.5% during the forecast period
The List of Companies - Embolotherapy Market
- Abbott Laboratories
- Boston Scientific Corporation
- Cook Medical LLC
- Johnson & Johnson Consumer Inc
- Medtronic
- Acandis GmbH
- Terumo Corporation
- Balt USA LLC
- Stryker Corporation
- Guerbet LLC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Aug 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Aug 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)